AbbVie voluntary admission: representative failed to meet ABPI exam requirements (AUTH/2990/11/17)

📅 2017 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/2990/11/17
CompanyAbbVie Ltd
Case typeVoluntary admission (treated as a complaint under Paragraph 5.6 of the Constitution and Procedure)
IssueFailure to comply with examination requirements for representatives
Applicable Code year2016
Breach clause(s)Clause 16.3
Representative start dateOctober 2015
Exam activity (as reported)One module passed (Nov 2016); two modules passed (Jul 2017); four modules attempted at least twice and not passed
Panel decisionBreach ruled
SanctionsUndertaking received; additional sanctions not stated
Voluntary admission received2 November 2017
Complaint received (PMCPA page)01 November 2017
Case completed12 January 2018
AppealNo appeal

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • AbbVie voluntarily admitted that one of its representatives had not taken an appropriate examination within one year of starting employment and had not passed it within the first two years.
  • The representative started as a representative in October 2015 (first role in the pharmaceutical industry).
  • Exam history provided: one module sat and passed in November 2016; two further modules sat and passed in July 2017; four other modules were each taken on at least two occasions and had not been passed.
  • Once identified (raised with HR in October 2017), the representative was withdrawn from the field and instructed not to communicate with customers directly or indirectly pending a disciplinary process.
  • AbbVie stated it had an SOP requiring the ABPI Examination and annual in-house Code training; it also implemented a new process in Q1 2017 for recording/monitoring representative education and said it would review the exam status of all representatives.
⚖️

Outcome

  • The Director treated the voluntary admission as a complaint (per Paragraph 5.6 of the Constitution and Procedure).
  • The Panel ruled a breach because the examination was not taken within the first year and not passed within two years.
  • No appeal.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training